TCWM
BBIO icon

Total Clarity Wealth Management’s BridgeBio Pharma BBIO Stock Holding History

Total Clarity Wealth Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$851K Sell
11,422
-2,260
-17% -$158K 0.17% 146
2026
Q1 		$1.02M Buy
13,682
+7,821
+133% +$567K 0.24% 104
2025
Q4 		$448K Buy
5,861
+1,511
+35% +$99.2K 0.11% 188
2025
Q3 		$226K Buy
+4,350
New +$212K 0.06% 258

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Total Clarity Wealth Management's BBIO Position: Q2 2026 in Review

Total Clarity Wealth Management reduced its BridgeBio Pharma (BBIO) stake by 17% in Q2 2026, selling an estimated $158K and leaving 11,422 shares worth $851K. The position accounts for 0.17% of the portfolio, ranked #146.

Total Clarity Wealth Management first reported a position in BBIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.02M in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Total Clarity Wealth Management held 11,422 shares of BridgeBio Pharma worth $851K as of Q2 2026.
  • Total Clarity Wealth Management sold 2,260 BridgeBio Pharma shares in Q2 2026, an estimated $158K.
  • BridgeBio Pharma made up 0.17% of Total Clarity Wealth Management's portfolio in Q2 2026, its #146 holding.
  • Total Clarity Wealth Management first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 4 quarters since.
  • Total Clarity Wealth Management's BridgeBio Pharma position peaked at $1.02M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Total Clarity Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.